Strength: 200 mg
Form: Tablets
Reference Brands: Plaquenil(US & EU)
Strength: 10 mg, 20 mg
Reference Brands: Arava(US & EU)
Strength: 500 mg, 1000 mg
Reference Brands: Azulfidine(US)
Strength: 25 mg/mL, 50 mg/mL, 250 mg/10 mL vial
Form: Injectable (IV, IM, Subcutaneous)
Reference Brands: Trexall (US)
Strength: Tab: 500,000 units, 1,000,000 units; Sus: 100,000 units/mL, 500,000 units/5 mL
Form: Tablets/Suspensions
Reference Brands: Mycostatin, Nilstat, Nystop(US)
Strength: 100,000 units/g, 100,000–300,000 units/g
Form: Topical Creams and Ointments
Strength: 50 mg, 100 mg/vial
Form: Intravenous (IV) Powder
Reference Brands: Mycamine(US & EU)
Strength: 50 mg/vial
Reference Brands: Eraxis(US)
Strength: 50 mg/vial, 70 mg/vial
Reference Brands: Cancidas (US & EU)
Strength: 10%
Form: Topical Solution
Reference Brands: Jublia(US)
Strength: 250 mg
Reference Brands: Lamisil(US & EU)
Strength: 2%, 4%
Form: Topical Creams/Ointments
Reference Brands: Daktarin(EU)
Strength: 2%, 120 mg (vaginal suppositories)
Form: Vaginal Creams and Suppositories
Reference Brands: Monistat(US & EU)
Strength: 10 mg, 100 mg, 200 mg (vaginal tablets), 1% (cream)
Form: Vaginal Tablets/Cream
Reference Brands: Mycelex(US); Fungusil(EU)
Strength: 1%, 2%
Reference Brands: Lotrimin(US); Canesten(EU)
Strength: 50 mg/5 mL; 125mg/5ml
Form: Suspension
Reference Brands: Grifulvin V(US); Griséofulvine(EU)
Strength: 125 mg, 250 mg, 500 mg
Form: Injection
Reference Brands: AmBisome(US & EU)
Strength: 50 mg/vial, 50 mg/mL
Form: Intravenous (IV) Injection
Reference Brands: Fungizone(EU & US)
Strength: 300 mg/100 mL
Form: Intravenous (IV) solution
Reference Brands: Noxafil(US & EU)
Stay updated on pharma trends and marketplace opportunities.